- Home
- MRK vs TMO Comparison
MRK vs TMO Comparison
Compare MRK & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- TMO
- Stock Information
- Founded
- MRK 2000
- TMO 1956
- Country
- MRK United States
- TMO United States
- Employees
- MRK N/A
- TMO N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- TMO Industrial Machinery/Components
- Sector
- MRK Health Care
- TMO Industrials
- Exchange
- MRK Nasdaq
- TMO Nasdaq
- Market Cap
- MRK 218.2B
- TMO 203.5B
- IPO Year
- MRK N/A
- TMO N/A
- Fundamental
- Price
- MRK $76.82
- TMO $402.68
- Analyst Decision
- MRK Buy
- TMO Buy
- Analyst Count
- MRK 15
- TMO 18
- Target Price
- MRK $113.71
- TMO $600.17
- AVG Volume (30 Days)
- MRK 14.7M
- TMO 2.8M
- Earning Date
- MRK 04-24-2025
- TMO 07-23-2025
- Dividend Yield
- MRK 4.22%
- TMO 0.43%
- EPS Growth
- MRK 667.14
- TMO 9.37
- EPS
- MRK 6.88
- TMO 17.06
- Revenue
- MRK $63,922,000,000.00
- TMO $42,898,000,000.00
- Revenue This Year
- MRK $2.42
- TMO $2.89
- Revenue Next Year
- MRK $5.64
- TMO $6.11
- P/E Ratio
- MRK $11.17
- TMO $23.62
- Revenue Growth
- MRK 4.10
- TMO 0.95
- 52 Week Low
- MRK $73.31
- TMO $390.50
- 52 Week High
- MRK $134.63
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- MRK 44.17
- TMO 41.60
- Support Level
- MRK $75.59
- TMO $400.39
- Resistance Level
- MRK $78.20
- TMO $407.37
- Average True Range (ATR)
- MRK 2.03
- TMO 10.81
- MACD
- MRK 0.21
- TMO 1.44
- Stochastic Oscillator
- MRK 44.10
- TMO 27.37
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).